Beneficial Effect of Left Ventricular Remodeling after Early Change of Sacubitril/Valsartan in Patients with Nonischemic DilatedAuthors : Hyue-Mee Kim et al.view more Reverse remodelling by sacubitril/valsartan predicts the prognosis in HFrEF fraction Authors : Mi-Gil Moon et al. view more The role of sacubitril/valsartan in the management of cardiac resynchronization therapy non‐responders: a retrospective analysisAuthors : Kyeong-Hyeon Chun et al.view more Changes in QRS Duration Are Associated with a Therapeutic Response to Sacubitril–valsartan in Heart Failure with Reduced EjectioAuthors : Bong-Joon Kim et al. view more Sacubitril/valsartan in patients with heart failure with reduced ejection fraction with end-stage of renal diseaseAuthors : Seonhwa Lee et al.view more Real-World Eligibility for Sacubitril/Valsartan in Heart Failure with Reduced Ejection Fraction Patients in Korea: Data from theAuthors : Jaewon Oh et al.view more ECG Monitoring of Reactions to Sacubitril-valsartan in Heart Failure with Reduced Ejection FractionAuthors : Min-Kyung Kang view more Eligibility and Usage of Sacubitril/Valsartan in KoreaAuthors : Jin-Jin Kim and Jong-Chan Yoon view more Angiotensin Receptor Neprilysin Inhibitor for Functional Mitral RegurgitationAuthors : Duk-Hyun Kang et al. view more
